Nanotech Investing Longeveron® Announces Third Quarter 2025 Financial Results and Provides Business Update 04 November
Nanotech Investing Longeveron® to Report Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025 28 October
Nanotech Investing Longeveron® Co-Founder and Chief Science Officer Dr. Joshua Hare Interviewed on NPR's BioTech Nation Discussing Potential Breakthrough Stem Cell Therapy for Hypoplastic Left Heart Syndrome , a Rare Pediatric Congenital Heart Defect 27 October
